Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals

Lucinda Furci(Vita-Salute San Raffaele University), Paolo Lusso(National Institute of Allergy and Infectious Diseases), Lucia Lopalco(Vita-Salute San Raffaele University), Giuseppe Tambussi(San Raffaele University of Rome), M Sinnone(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Patrizia Loverro(Institute of Human Virology)
AIDS
May 1, 2002
10.1097/00002030-200205030-00006
Cited by 29

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391